Shiela Rhoads, MD
Gastroenterology · la Grange, KYNPI 1265638407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $664, 2.6 times the $258 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in KY, where the typical reported total is $3,388.
Across 113 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$425
- Johnson & Johnson$374
- AbbVie$253
- Merck$253
- QOL Medical, LLC$232
- Takeda Pharmaceuticals U.S.A., Inc.$226
- plus $490 from 13 others
What the payments were for
- Food & beverage$2,23399%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $425 |
| Johnson & Johnson(2 entities) | 20 | $374 |
| AbbVie | 13 | $253 |
| Merck | 14 | $253 |
| QOL Medical, LLC | 9 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $226 |
| Ardelyx, Inc. | 4 | $101 |
| Sanofi | 3 | $67 |
| Braintree Laboratories, Inc. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Evoke Pharma, Inc. | 3 | $46 |
| Bristol Myers Squibb | 2 | $41 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Shionogi Inc | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$2,253 in reported general payments places this provider in the 40th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 23 | $13,957 |
| Sucralfate | 35 | $2,900 |
| Omeprazole | 144 | $1,225 |
| Budesonide DrBudesonide | 15 | $1,088 |
| Pantoprazole Sodium | 122 | $1,013 |
| CholestyramineCholestyramine (With Sugar) | 12 | $983 |
| Esomeprazole Magnesium | 30 | $612 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 16 | $583 |
| Ondansetron Hcl | 16 | $499 |
| Famotidine | 35 | $403 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 13 | $386 |
| Ondansetron OdtOndansetron | 20 | $284 |
| Dicyclomine Hcl | 18 | $214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $253 | $13,95723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 207 gastroenterology providers in Kentucky.
Other gastroenterology in la Grange
- Harrison Daniella Grange$8K
- Gerald DrydenLouisville$2.1M
- Zahid SaeedCrestview Hills$442K
- Matthew CaveLouisville$340K
- Michael KreaseLouisville$322K
- Sunana SohiLouisville$220K
- Jeffrey TuvlinLouisville$202K
- Stephen McClaveLouisville$124K
- Uday ShankarHazard$64K
- Terrence BarrettLexington$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.